A 12-week open trial of fluoxetine in 61 obsessive-compulsive disorder
patients significantly improved depressive and obsessive-compulsive
symptoms. Baseline depression scores were not related to improvement on two
obsessive-compulsive scales. The results reinforce the hypothesis of
serotonergic abnormalities in obsessive-compulsive disorder.Abstract Teaser